| 1. |
- Xu, Changdan, et al.
(författare)
-
CTCs Detection and Whole-exome Sequencing Might Be Used to Differentiate Benign and Malignant Pulmonary Nodules
- 2023
-
Ingår i: Chinese Journal of Lung Cancer. - 1009-3419. ; 26:6, s. 449-460
-
Tidskriftsartikel (refereegranskat)abstract
- Background and objective Low-density computed tomography (LDCT) improved early lung cancer diagnosis but introduces an excess of false-positive pulmonary nodules data. Hence, accurate diagnosis of early-stage lung cancer remains challenging. The purpose of the study was to assess the feasibility of using circulating tumour cells (CTCs) to differentiate malignant from benign pulmonary nodules. Materials and methods 122 patients with suspected malignant pulmonary nodules detected on chest CT in preparation for surgery were prospectively recruited. Peripheral blood samples were collected before surgery, and CTCs were identified upon isolation by size of epithelial tumour cells and morphological analysis. Laser capture microdissection, MALBAC amplification, and whole-exome sequencing were performed on 8 samples. The diagnostic efficacy of CTCs counting, and the genomic variation profile of benign and malignant CTCs samples were analysed. Results Using 2.5 cells/5 mL as the cut-off value, the area under the receiver operating characteristic curve was of 0.651 (95% confidence interval: 0.538-0.764), with a sensitivity and specificity of 0.526 and 0.800, respectively, and positive and negative predictive values of 91.1% and 30.3%, respectively. Distinct sequence variations differences in DNA damage repair-related and driver genes were observed in benign and malignant samples. TP53 mutations were identified in CTCs of four malignant cases; in particular, g.7578115T>C, g.7578645C>T, and g.7579472G>C were exclusively detected in all four malignant samples. Conclusion CTCs play an ancillary role in the diagnosis of pulmonary nodules. TP53 mutations in CTCs might be used to identify benign and malignant pulmonary nodules.
|
|
| 2. |
- Sukhrobov, Parviz, et al.
(författare)
-
Nonenzymatic Glucose Biosensor Based on NiNPs/Nafion/Graphene Film for Direct Glucose Determination in Human Serum
- 2018
-
Ingår i: NANO. - 1793-2920 .- 1793-7094. ; 13:7
-
Tidskriftsartikel (refereegranskat)abstract
- This study describes a type of novel nickel nanoparticles (NiNPs) decorated on Nafiongraphene composite film by using the electrochemical deposition method. It was used to fabricate electrochemical biosensors for sensitive nonenzymatic glucose detection. Compared with the Nafion-graphene film and NiNPs-modified glassy carbon electrode (NiNPs-GCE), the NiNPs/Nafion/graphene/GCE showed the best electrocatalytic activity towards glucose oxidation in alkaline medium. The NiNPs/Nafion/graphene/GCE at an applied potential of +0.55 V in a linear range of 1-200 mu M presented a high sensitivity of 3437.25 mu A center dot mM(-1) cm(-2) with coefficient of correlation R-2 = 0.999; and in a linear range of 200-10800 mu M it performed the best sensitivity of 2848.6 mu A center dot mM(-1) cm(-2) with coefficient of correlation R-2 = 0.995 towards glucose oxidation. For a concentration up to 200 mu M, a linear range was obtained with a limit of detection of 0.6 mu M (signal to noise = 3) and as much as 10 800 mu M with a limit of detection of 0.82 mu M (signal to noise = 3). The time of responses was about 1-1.5 s with the addition of 0.1-1 mM glucose. In addition, NiNPs/Nafion/graphene/GCE also has a high anti-interference ability toward common oxidative interfering species, such as uric acid, ascorbic acid and dopamine. More importantly, NiNPs/Nafion/graphene/GCE was successfully used for the determination of glucose concentration in human serum samples in comparison with a local hospital. The NiNPs/Nafion/graphene/GCE exhibited high sensitivity, low working potential, good stability, excellent electrical properties, enhanced selectivity and fast amperometric responses to glucose oxidation. Thus, as a nonenzymatic sensor, it is promising for future glucose determination development.
|
|
